(Q33577149)

28 July 2017

1 reference

title

Intrathecal liposomal cytarabine: more friend than foe? (English)

1 reference

28 July 2017

1 reference

Deepa Bhojwani

1

0 references

Ching-Hon Pui

series ordinal

2

object named as

Ching-Hon Pui

1 reference

28 July 2017

publication date

1 August 2008

1 reference

28 July 2017

1 reference

28 July 2017

volume

49

1 reference

28 July 2017

issue

8

1 reference

28 July 2017

page(s)

1427-1430

1 reference

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2803076

Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2803076

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2803076

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2803076

Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases

21 June 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802220527

Extended CSF cytarabine exposure following intrathecal administration of DTC 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802220527

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802220527

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802220527

Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802220527

Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2803076

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

31 October 2018

1 reference

12 December 2020

Results of Compassionate Therapy with Intrathecal Depot Liposomal Cytarabine in Acute Myeloid Leukemia Meningeosis

1 reference

12 December 2020

Toward optimal use of intrathecal liposomal cytarabine

1 reference

12 December 2020

Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.

1 reference

12 December 2020

10.1080/10428190802220527

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference